-
Signature
-
/s/ Ernest C. Garcia II
-
Issuer symbol
-
CVNA
-
Transactions as of
-
03 Jun 2025
-
Net transactions value
-
-$33,731,275
-
Form type
-
4
-
Filing time
-
05 Jun 2025, 17:25:41 UTC
Reporting Owners (2)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| GARCIA ERNEST C. II |
10%+ Owner |
1720 W. RIO SALADO PARKWAY, SUITE A, TEMPE |
/s/ Ernest C. Garcia II |
05 Jun 2025 |
0001017608 |
| ECG II SPE, LLC |
10%+ Owner |
1720 W. RIO SALADO PARKWAY, SUITE A, TEMPE |
/s/ Ernest C. Garcia II, ECG II SPE, LLC |
05 Jun 2025 |
0001754720 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CVNA |
Class A Common Stock |
Conversion of derivative security |
|
+50,000 |
|
|
50,000 |
03 Jun 2025 |
Direct |
F1 |
| transaction |
CVNA |
Class A Common Stock |
Sale |
$1,433,561 |
-4,308 |
-8.6% |
$332.77 |
45,692 |
03 Jun 2025 |
Direct |
F2, F3 |
| transaction |
CVNA |
Class A Common Stock |
Sale |
$2,495,730 |
-7,475 |
-16% |
$333.88 |
38,217 |
03 Jun 2025 |
Direct |
F2, F3 |
| transaction |
CVNA |
Class A Common Stock |
Sale |
$5,566,307 |
-16,626 |
-44% |
$334.80 |
21,591 |
03 Jun 2025 |
Direct |
F2, F3 |
| transaction |
CVNA |
Class A Common Stock |
Sale |
$5,758,378 |
-17,145 |
-79% |
$335.86 |
4,446 |
03 Jun 2025 |
Direct |
F2, F3 |
| transaction |
CVNA |
Class A Common Stock |
Sale |
$799,685 |
-2,376 |
-53% |
$336.57 |
2,070 |
03 Jun 2025 |
Direct |
F2, F3 |
| transaction |
CVNA |
Class A Common Stock |
Sale |
$698,592 |
-2,070 |
-100% |
$337.48 |
0 |
03 Jun 2025 |
Direct |
F2, F3 |
| transaction |
CVNA |
Class A Common Stock |
Conversion of derivative security |
|
+50,000 |
|
|
50,000 |
04 Jun 2025 |
Direct |
F1 |
| transaction |
CVNA |
Class A Common Stock |
Sale |
$2,475,275 |
-7,324 |
-15% |
$337.97 |
42,676 |
04 Jun 2025 |
Direct |
F2, F4 |
| transaction |
CVNA |
Class A Common Stock |
Sale |
$3,277,189 |
-9,666 |
-23% |
$339.04 |
33,010 |
04 Jun 2025 |
Direct |
F2, F4 |
| transaction |
CVNA |
Class A Common Stock |
Sale |
$8,850,362 |
-26,041 |
-79% |
$339.86 |
6,969 |
04 Jun 2025 |
Direct |
F2, F4 |
| transaction |
CVNA |
Class A Common Stock |
Sale |
$2,307,889 |
-6,769 |
-97% |
$340.95 |
200 |
04 Jun 2025 |
Direct |
F2, F4 |
| transaction |
CVNA |
Class A Common Stock |
Sale |
$68,309 |
-200 |
-100% |
$341.54 |
0 |
04 Jun 2025 |
Direct |
F2 |
| transaction |
CVNA |
Class B Common Stock |
Other |
|
-50,000 |
-0.13% |
|
37,292,317 |
03 Jun 2025 |
Direct |
F5 |
| transaction |
CVNA |
Class B Common Stock |
Other |
|
-50,000 |
-0.13% |
|
37,242,317 |
04 Jun 2025 |
Direct |
F5 |
| holding |
CVNA |
Class B Common Stock |
|
|
|
|
|
8,000,000 |
03 Jun 2025 |
ECG II SPE, LLC |
F6 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CVNA |
Class A Units |
Conversion of derivative security |
$0 |
-62,500 |
-0.13% |
$0.000000 |
46,615,395 |
03 Jun 2025 |
Class A Common Stock |
50,000 |
|
Direct |
F1 |
| transaction |
CVNA |
Class A Units |
Conversion of derivative security |
$0 |
-62,500 |
-0.13% |
$0.000000 |
46,552,895 |
04 Jun 2025 |
Class A Common Stock |
50,000 |
|
Direct |
F1 |
| holding |
CVNA |
Class A Units |
|
|
|
|
|
10,000,000 |
03 Jun 2025 |
Class A Common Stock |
10,000,000 |
$0.000000 |
ECG II SPE, LLC |
F7 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: